SearchSkip to Search Results
- 2Randomized Controlled Trials as Topic
- 1Analgesics, Opioid
- 4Graduate Studies and Research, Faculty of
- 4Graduate Studies and Research, Faculty of/Theses and Dissertations
- 1Surgery, Department of
- 1Surgery, Department of/Centre for the Advancement of Minimally Invasive Surgery
- 1Pediatrics, Department of
- 1Pediatrics, Department of/Complementary and Alternative Research and Education (CARE)
Stroke is a leading cause of disability in Canada. Delayed hypothermia improves outcome in patients following cardiac arrest and reduces lesion volume in rodents after transient focal ischemia, but less is known about the effectiveness of delayed hypothermia following permanent focal ischemia. In...
Hypoxic-ischemic brain damage (HIBD) is still of major concern in the neonatal period, resulting in chronic neurological sequelae stemming from damage to the term newborn brain. Full-body and focal-head cooling within 6 hours of birth have proven neuroprotective in human newborns and various...
Influence of therapeutic hypothermia on neuroprotection and post-ischemic plasticity in a rat model of global ischemiaDownload
Blood flow to the brain may be disrupted by either a stroke (such as focal ischemia or hemorrhage) or cardiac arrest, where the whole brain becomes ischemic. Both forms of injury result in irreversible neuronal loss leading to neurological impairments and a decrease in the quality of life....
Mild therapeutic hypothermia (HYPO), decreasing brain temperature to 32-35°C, is the gold standard neuroprotectant against ischemia. Cooling also ameliorates several cell death mechanisms in other types of brain injury (e.g., traumatic brain injury). As with many other neuroprotectants, HYPO not...